BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 34145845)

  • 1. [Effectiveness of different screening strategies for cardiovascular diseases prevention in a community-based Chinese population: A decision-analytic Markov model].
    Liu QP; Chen XJ; Wang JM; Liu XF; Si YQ; Liang JY; Shen P; Lin HB; Tang X; Gao P
    Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Jun; 53(3):460-466. PubMed ID: 34145845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effectiveness of statin treatment strategies for primary prevention of cardiovascular diseases in a community-based Chinese population: A decision-analytic Markov model].
    Gong C; Liu QP; Wang JM; Liu XF; Zhang ML; Yang H; Shen P; Lin HB; Tang X; Gao P
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Jun; 54(3):443-449. PubMed ID: 35701120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effectiveness of different screening strategies for type 2 diabete on preventing cardiovascular diseases in a community-based Chinese population using a decision-analytic Markov model].
    Wang JM; Liu QP; Zhang ML; Gong C; Liu SD; Chen WY; Shen P; Lin HB; Gao P; Tang X
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Jun; 54(3):450-457. PubMed ID: 35701121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effectiveness of different screening strategies for primary prevention of cardiovascular diseases in a rural northern Chinese population].
    Si YQ; Tang X; Zhang DD; He L; Cao Y; Wang JW; Li N; Liu JJ; Gao P; Hu YH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Jun; 50(3):443-449. PubMed ID: 29930411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of initiation of antihypertensive therapy strategies for primary prevention of cardiovascular diseases in Chinese population: A decision-analytic Markov modelling study].
    Zhou T; Liu Q; Zhang M; Liu X; Kang J; Shen P; Lin H; Tang X; Gao P
    Beijing Da Xue Xue Bao Yi Xue Ban; 2024 Jun; 56(3):441-447. PubMed ID: 38864129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of aspirin treatment strategies for primary prevention of cardiovascular diseases: A decision-analytic Markov modelling study].
    Zhang ML; Liu QP; Gong C; Wang JM; Zhou TJ; Liu XF; Shen P; Lin HB; Tang X; Gao P
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Jun; 55(3):480-487. PubMed ID: 37291924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population Genomic Screening for Three Common Hereditary Conditions : A Cost-Effectiveness Analysis.
    Guzauskas GF; Garbett S; Zhou Z; Schildcrout JS; Graves JA; Williams MS; Hao J; Jones LK; Spencer SJ; Jiang S; Veenstra DL; Peterson JF
    Ann Intern Med; 2023 May; 176(5):585-595. PubMed ID: 37155986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of China's Low Centralized Medicine Procurement Prices on the Cost-Effectiveness of Statins for the Primary Prevention of Atherosclerotic Cardiovascular Disease.
    Wang M; Liu J; Bellows BK; Qi Y; Sun J; Liu J; Moran AE; Zhao D
    Glob Heart; 2020 Jun; 15(1):43. PubMed ID: 32923337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic Evaluation of the 2016 Chinese Guideline and Alternative Risk Thresholds of Initiating Statin Therapy for the Management of Atherosclerotic Cardiovascular Disease.
    Jiang Y; Ni W
    Pharmacoeconomics; 2019 Jul; 37(7):943-952. PubMed ID: 30875022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of Low-Dose Computed Tomography With a Plasma-Based Biomarker for Lung Cancer Screening in China.
    Zhao Z; Wang Y; Wu W; Yang Y; Du L; Dong H
    JAMA Netw Open; 2022 May; 5(5):e2213634. PubMed ID: 35608858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cost-effectiveness of community-based treatment of chronic hepatitis B in China].
    Zhang SX; Yang PC; Cai YL; Lin Y; Zou YH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Jul; 38(7):860-867. PubMed ID: 28738456
    [No Abstract]   [Full Text] [Related]  

  • 13. Cost-effectiveness analysis of artificial intelligence-based diabetic retinopathy screening in rural China based on the Markov model.
    Li H; Li G; Li N; Liu C; Yuan Z; Gao Q; Hao S; Fan S; Yang J
    PLoS One; 2023; 18(11):e0291390. PubMed ID: 37971984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screen-and-treat strategies for albuminuria to prevent cardiovascular and renal disease: cost-effectiveness of nationwide and targeted interventions based on analysis of cohort data from the Netherlands.
    Boersma C; Gansevoort RT; Pechlivanoglou P; Visser ST; van Toly FF; de Jong-van den Berg LT; de Jong PE; Postma MJ;
    Clin Ther; 2010 Jun; 32(6):1103-21. PubMed ID: 20637965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-Effectiveness Analysis of Screening for and Managing Identified Hypertension for Cardiovascular Disease Prevention in Vietnam.
    Nguyen TP; Wright EP; Nguyen TT; Schuiling-Veninga CC; Bijlsma MJ; Nguyen TB; Postma MJ
    PLoS One; 2016; 11(5):e0155699. PubMed ID: 27192051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness and cost-utility of population-based glaucoma screening in China: a decision-analytic Markov model.
    Tang J; Liang Y; O'Neill C; Kee F; Jiang J; Congdon N
    Lancet Glob Health; 2019 Jul; 7(7):e968-e978. PubMed ID: 31122906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of implementing risk-based cardiovascular disease (CVD) management using updated WHO CVD risk prediction charts in India.
    Sivanantham P; S MK; Essakky S; Singh M; Ghosh S; Mehndiratta A; Kar SS
    PLoS One; 2023; 18(8):e0285542. PubMed ID: 37624838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of universal screening for chronic hepatitis B virus infection in China: an economic evaluation.
    Su S; Wong WC; Zou Z; Cheng DD; Ong JJ; Chan P; Ji F; Yuen MF; Zhuang G; Seto WK; Zhang L
    Lancet Glob Health; 2022 Feb; 10(2):e278-e287. PubMed ID: 35063115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-Effectiveness of Primary Prevention with Statin Treatment for Chinese Patients with Type 2 Diabetes.
    Li T; Wan X; Ma J; Wu B
    Adv Ther; 2018 Dec; 35(12):2214-2223. PubMed ID: 30390239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Who needs laboratories and who needs statins?: comparative and cost-effectiveness analyses of non-laboratory-based, laboratory-based, and staged primary cardiovascular disease screening guidelines.
    Pandya A; Weinstein MC; Salomon JA; Cutler D; Gaziano TA
    Circ Cardiovasc Qual Outcomes; 2014 Jan; 7(1):25-32. PubMed ID: 24425701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.